|41.5 0 (0%)||11-28 14:40|
|Targets||6-month :||49.5||1-year :||51.36|
|Resists||First :||42.38||Second :||43.97|
|Supports||First :||39.81||Second :||33.12|
|MAs||MA(5) :||41.62||MA(20) :||41.65|
|MA(100) :||43.21||MA(250) :||43.19|
|MACD||MACD :||-0.4||Signal :||-0.5|
|%K %D||K(14,3) :||46.2||D(3) :||48.7|
|52-week||High :||47.59||Low :||36.61|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NRC ] has closed above bottom band by 48.1%. Bollinger Bands are 48.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||41.81 - 42.1||42.1 - 42.32|
|Low:||40.37 - 40.77||40.77 - 41.08|
|Close:||40.95 - 41.49||41.49 - 41.9|
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Mon, 27 Nov 2023
THIS WEEK - AIP.ORG - American Institute of Physics
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Health Information Services
|Shares Out||25 (M)|
|Shares Float||14 (M)|
|Held by Insiders||41.8 (%)|
|Held by Institutions||47.4 (%)|
|Shares Short||96 (K)|
|Shares Short P.Month||311 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||2.35|
|Profit Margin||19.3 %|
|Operating Margin||26.2 %|
|Return on Assets (ttm)||19.8 %|
|Return on Equity (ttm)||45.7 %|
|Qtrly Rev. Growth||0.6 %|
|Gross Profit (p.s.)||3.84|
|Sales Per Share||6.05|
|Qtrly Earnings Growth||-3 %|
|Operating Cash Flow||35 (M)|
|Levered Free Cash Flow||12 (M)|
|Price to Book value||17.58|
|Price to Sales||6.85|
|Price to Cash Flow||29.53|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|